Multiple Assemblies exist for SMTL entry 3zc6
Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor; X-RAY DIFFRACTION 2.42 Å

	SMTL ID 3zc6.1 Ligands N-[(2R)-1-(3-cyanoazetidin-1-yl)-1-oxidanylidene-propan-2-yl]-2-(6-fluoranyl-1-methyl-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide; DI(HYDROXYETHYL)ETHER; CHLORIDE ION Polypeptides TYROSINE-PROTEIN KINASE JAK3 Oligo-state monomer
	SMTL ID 3zc6.2 Ligands N-[(2R)-1-(3-cyanoazetidin-1-yl)-1-oxidanylidene-propan-2-yl]-2-(6-fluoranyl-1-methyl-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide; TETRAETHYLENE GLYCOL; DI(HYDROXYETHYL)ETHER Polypeptides TYROSINE-PROTEIN KINASE JAK3 Oligo-state monomer
	SMTL ID 3zc6.3 Ligands N-[(2R)-1-(3-cyanoazetidin-1-yl)-1-oxidanylidene-propan-2-yl]-2-(6-fluoranyl-1-methyl-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide; TETRAETHYLENE GLYCOL Polypeptides TYROSINE-PROTEIN KINASE JAK3 Oligo-state monomer
	SMTL ID 3zc6.4 Ligands N-[(2R)-1-(3-cyanoazetidin-1-yl)-1-oxidanylidene-propan-2-yl]-2-(6-fluoranyl-1-methyl-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide; CHLORIDE ION Polypeptides TYROSINE-PROTEIN KINASE JAK3 Oligo-state monomer